By Kevin Madagan
Carlyle (NASDAQ: CG) and SK Capital Partners will acquire bluebird bio (NASDAQ: BLUE), according to a news release.
bluebird, founded in 2010 and based in Somerville, Massachusetts, is a gene therapy maker.
Carlyle, with
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle and SK Capital to Acquire bluebird bio